Skip to main content
logo
Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
49.03
+1.23 (2.57%)
Jun 18, 2026, 3:04 PM CST

SHE:002653 Revenue

Haisco Pharmaceutical Group had revenue of 1.56B CNY in the quarter ending March 31, 2026, with 75.33% growth. This brings the company's revenue in the last twelve months to 5.06B, up 31.04% year-over-year. In the year 2025, Haisco Pharmaceutical Group had annual revenue of 4.39B with 17.91% growth.

Revenue (ttm)
5.06B
Revenue Growth
+31.04%
P/S Ratio
10.75
Revenue / Employee
904.01K
Employees
5,597
Market Cap
54.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.39B666.44M17.91%
Dec 31, 20243.72B366.28M10.92%
Dec 31, 20233.36B339.78M11.27%
Jan 1, 20233.02B241.98M8.73%
Jan 1, 20222.77B-556.28M-16.71%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pharmaron Beijing14.57B
Chongqing Zhifei Biological Products8.75B
Asymchem Laboratories (Tianjin)6.93B
Shanghai RAAS Blood Products6.85B
Beijing Tiantan Biological Products5.99B
Shanghai Allist Pharmaceuticals5.67B
Hualan Biological Engineering4.49B
Sunshine Guojian Pharmaceutical (Shanghai)4.32B
Revenue Rankings

Haisco Pharmaceutical Group News

More News